DXCM DEXCOM INC.

Dexcom Brings Mentorship to Centerfield, Welcomes New, Star Athletes to Its Ground-breaking NIL Program Dexcom U

(NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, announced today the launch of the third season of , the company’s groundbreaking NIL (name, image, likeness) program exclusively for college athletes with diabetes.

This press release features multimedia. View the full release here:

The Dexcom U 2024 roster consists of 20 athletes who all use Dexcom CGM to monitor their glucose levels and manage their diabetes (Graphic: Dexcom)

The Dexcom U 2024 roster consists of 20 athletes who all use Dexcom CGM to monitor their glucose levels and manage their diabetes (Graphic: Dexcom)

Heralded by Ad Age as a after its inaugural season in 2022, the 2024 Dexcom U season welcomes four new athletes from top schools including Alabama A&M, University of Southern California, University of Missouri and Florida Gulf Coast University. The roster includes 20 athletes across 12 different sports including beach volleyball, water polo, lacrosse, cheerleading and more.

All Dexcom U athletes use Dexcom continuous glucose monitoring (CGM) technology to manage their diabetes. Dexcom CGMs consist of a small, wearable sensor that continually measures and sends glucose data wirelessly to a smart device* or receiver, giving users accurate1 real-time glucose data that empowers them to train and compete at a high level, breaking new barriers in their respective sports.

“Heading into year three of this unique program, we want to amplify the impact Dexcom U athletes are making on the next generation of people with diabetes,” said Teri Lawver, executive vice president and chief commercial officer at Dexcom. “After supporting nearly 30 college athletes since the program’s inception in 2022, with multiple reaching professional ranks, our Dexcom U roster is proof that with the right support and technology, people with diabetes can achieve their athletic dreams.”

With research that reveals representation for people with diabetes can help inspire up-and-coming college and professional athletes2, Dexcom has doubled down on fuelling mentorships between aspiring young athletes and those playing at the collegiate or pro levels.

To bring the program’s mentorship pillar to life, Dexcom hosted the first-ever Dexcom U Sports Camp in San Diego during the offseason. The camp brought together professional athletes including Indianapolis Colts wide receiver Adonai Mitchell and Miami Dolphins long snapper Blake Ferguson, Dexcom U team members and young athletes ranging from ages 11 to 15 — all who have three things in common: a diabetes diagnosis, a passion for sports, and pride in wearing Dexcom CGM technology like Dexcom G7. At the camp, Dexcom U athletes were paired with mentees following a dynamic day of activities. Since then, they regularly check in on each other, offering support and reminders that diabetes doesn’t have to hold them back.

The Dexcom U 2024 roster consists of 20 athletes, with four new and 16 returning members, who all use Dexcom CGM to monitor their glucose levels and manage their diabetes:

  • Amber Jackson, Track & Field, University of Louisville
  • Ava DeStefon, Cheerleading, Clemson University
  • Ben Mirisch, Water Polo, University of Southern California
  • Bri Carrasquillo, Lacrosse, University of Oregon
  • Caleb Fauria, Football, University of Delaware
  • Dante Vasquez, Football, Springfield College
  • Isaac Traudt, Basketball, Creighton University
  • Jaci Carpenter, Beach Volleyball, Florida Gulf Coast University
  • Jaxon Dowell, Golf, University of Oklahoma
  • Jessica Walter, Softball, Providence College
  • Joshua Meriwether, Football, Tennessee State University
  • Leo Giannoni, Baseball, Florida Gulf Coast University
  • Madison Moraja, Track & Field, North Carolina State University
  • Marlee Fray, Soccer, Oral Roberts University
  • Nicholas Hahne, Cheerleading, University of Notre Dame
  • Paris Husic, Track & Field, Clemson University
  • Raegan Lantz, Volleyball, Miami (OH) University
  • Sam Horn, Football & Baseball, University of Missouri
  • Shelomi Sanders, Basketball, Alabama A&M
  • Tristan Wakefield, Rowing, Syracuse University

“I joined Dexcom U because it’s important to me to share my story to be a voice for others and show I won’t be deterred from achieving my goals despite living with diabetes,” said Shelomi Sanders, first-year member of Dexcom U and basketball player at Alabama A&M. “Not only does my Dexcom G7 give me and my loved ones peace of mind, but the connectivity features I’m able to tap into through my automated insulin delivery system help me elevate my game to the next level.”

Dexcom will continue to offer free educational resources to help other athletes with diabetes better understand how to manage their condition. These resources also help parents, coaches and teammates better understand the disease and learn how to support those with diabetes. These resources consist of first-hand advice from Dexcom U athletes as well as tips for the next generation of athletes with diabetes so they can better manage their condition, stay active and feel their best physically and mentally – on and off the field.

“Being part of such a special program like Dexcom U means the world to me, and it’s empowering to know there’s a community out there that understands the additional hurdles that athletes with diabetes have to overcome,” said Joshua Meriwether, second-year member of the program and football player at Tennessee State University. “As a young teenager I dreamed of having a support system like I do with my Dexcom U teammates, so being able to mentor and inspire the next generation of athletes with diabetes is extremely rewarding.”

To learn more about Dexcom U and access the educational resources, visit .

About Dexcom, Inc.

DexCom, Inc. empowers people to take control of health through innovative continuous glucose monitoring (CGM) systems. Headquartered in San Diego, Calif., and with operations across Europe and select parts of Asia/Oceania, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of users, caregivers and providers, Dexcom works to simplify and improve diabetes management around the world. For more information on Dexcom, visit .

*Smart device sold separately. For a list of compatible devices, visit .

1 Welsh JB, et al. J Diabetes Sci Technol. 2024;18(1):143-7.

2 Dexcom, U.S. data on file, September 2022

EN
18/09/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on DEXCOM INC.

Research Team ACF
  • Research Team ACF

KDST + NLSP Combined Core Investment Case 29052025

We consider the merged platform Kadimastem (KDST.TA) + NLS Pharmaceutics (NLSP:NasdaqCM). We provide an investment case analysis and a selection of merged metrics prior to any synergies. The merger creates a cross-platform pre-revenue biotech with lead programs including a proprietary stem-differentiation platform capable of delivering scalable therapies for replacing lost or damaged cells; IsletRx could revolutionize insulin production for Type 1 diabetes (T1D) patients; AstroRx® targets neurod...

Dexcom Inc: 2 directors

Two Directors at Dexcom Inc sold 16,184 shares at between 84.285USD and 85.110USD. The significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last ...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Booster Shots: Attractive bottom-fishing stocks

For investors looking for bottom-fishing candidates; stocks that are breaking downtrends, exhibiting ascending reaction lows, and showing stabilizing relative strength.

OSK OSHKOSH CORP
DXCM DEXCOM INC.
XRAY DENTSPLY SIRONA INC.
WING WINGSTOP INC.
VRTS VIRTUS INVESTMENT PARTNERS INC.
UHS UNIVERSAL HEALTH SERVICES INC. CLASS B
STKS ONE GROUP HOSPITALITY
SNPS SYNOPSYS INC.
SMG SCOTTS MIRACLE-GRO COMPANY CLASS A
SFST SOUTHERN FIRST BANCSHARES
RGNX REGENXBIO INC.
RCKY ROCKY BRANDS
PRGO PERRIGO CO. PLC
MPWR MONOLITHIC POWER SYSTEMS INC.
JRVR JAMES RIVER GROUP HOLDINGS LTD
IRM IRON MOUNTAIN INC.
GPC GENUINE PARTS COMPANY
GD GENERAL DYNAMICS CORPORATION
DLTR DOLLAR TREE INC.
DG DOLLAR GENERAL CORPORATION
CROX CROCS INC.
CAL CALERES INC.
BKE BUCKLE INC.
ASC ARDMORE SHIPPING
AMOT ALLIED MOTION TECHNOLOGIES
ACAD ACADIA PHARMACEUTICALS INC.
SBL SAFE BULKERS INC.
LPG DORIAN LPG
MEG. MEG ENERGY CORP.
MDU MDU RESOURCES GROUP INC
NAT NORDIC AMERICAN TANKERS LIMITED
EVTC EVERTEC INC.
FSLR FIRST SOLAR INC.
IONS IONIS PHARMACEUTICALS INC.
NMIH NMI HOLDINGS INC. CLASS A
AGYS AGILYSYS INC.
SJM J.M. SMUCKER COMPANY
FIZZ NATIONAL BEVERAGE CORP.
NHC NATIONAL HEALTHCARE CORP.
INSW INTERNATIONAL SEAWAYS INC.
FLGT FULGENT GENETICS
DK DELEK US HOLDINGS INC
CELH CELSIUS HOLDINGS INC.
AMD ADVANCED MICRO DEVICES INC.
TTEC TTEC HOLDINGS INC.
AVGO BROADCOM INC.
ST SENSATA TECHNOLOGIES HOLDING PLC
ELAN ELANCO ANIMAL HEALTH INC.
MEC MAYVILLE ENGINEERING
DELL DELL TECHNOLOGIES INC CLASS C
CSTM CONSTELLIUM SE CLASS A
OI O-I GLASS INC
BWMN BOWMAN CONSULTING GROUP LTD
DINO HOLLYFRONTIER CORP
EVEX EVE HOLDING INC
SPXC SPX TECHNOLOGIES INC
WEST WESTROCK COFFEE COMPANY LLC
ADCT ADC THERAPEUTICS SA
SVV SAVERS VALUE VILLAGE INC
GUTS FRACTYL HEALTH INC
AGEN AGENUS INC.
ARDT ARDENT HEALTH PARTNERS INC
PCT PROVIDENT CAP TR II SKIS 8.75%29
MKTW MARKETWISE INC
 PRESS RELEASE

Dexcom Report Unveiled at ATTD 2025 Reveals HCPs Favour Tech Over Medi...

EDINBURGH, Scotland & SAN DIEGO--(BUSINESS WIRE)-- (NASDAQ: DXCM), a global leader in glucose biosensing, today announced the launch of its first multi-region report, the "Dexcom State of Type 2 Report: Access and Attitudes Across Europe and the Middle East." The report surveyed over 2,500 people, made up of individuals with Type 2 diabetes and healthcare professionals, from Germany, Italy, the Netherlands, Saudi Arabia, Spain and the United Kingdom. The findings provide valuable insights into access to care and perceptions of diabetes technology. During the conference, first-ever accuracy a...

Research Team ACF
  • Research Team ACF

ACF Thematic Research Regenerative Medicine Diabetes Treatment & Innov...

Diabetes mellitus, Type 1 (T1D) and Type 2 (T2D, 85-90% of cases), is a USD ~75bn global therapy market. Global economic costs of diabetes may exceed USD1 trn today and USD 450bn in the US, suggesting a pressing global health challenge. Diabetes is a chronic metabolic disorder characterized by high blood sugar levels. In 2024, consensus global estimates suggested there were ~800m adult diabetes sufferers. In 2021, according to the IDF there >530m sufferers globally. For 2027E we modestly forecas...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch